PharmiWeb
Modular Medical Announces Proof-of-Concept Study for Personalized Metabolic Therapy utilizing the MO
SAN DIEGO, CA / ACCESSWIRE / July 15, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company seeking to launch the next generation ...
21 hours ago